Profile
General Information
Mevacor has been approved for the primary prevention of coronary heart disease in patients without symptomatic cardiovascular disease who have average to moderately elevated total-C and LDL-C and below average HDL-C.
Approval Date: 1999-03-01
Date Created: 1999-07-15 12:00:00
Company Name: Merck
